We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA icon
151
Electronic Arts
EA
$52.4B
$22.3M 0.15%
201,249
-1,043
-0.5% -$122K
TENB icon
152
Tenable Holdings
TENB
$3.46B
$22.3M 0.15%
509,808
PLD icon
153
Prologis
PLD
$137B
$22.2M 0.15%
193,224
-81,966
-30% -$10.1M
TD icon
154
Toronto Dominion Bank
TD
$199B
$22.2M 0.15%
402,960
-157,292
-28% -$10.2M
PDD icon
155
Pinduoduo
PDD
$122B
$21.7M 0.15%
310,940
+86,940
+39% +$7.86M
VIPS icon
156
Vipshop
VIPS
$7.13B
$21.4M 0.15%
1,531,480
+1,061,630
+226% +$15.8M
NFLX icon
157
Netflix
NFLX
$301B
$21.4M 0.15%
672,620
+15,770
+2% +$522K
FTV icon
158
Fortive
FTV
$19.5B
$21.4M 0.15%
451,850
+14,615
+3% +$735K
AMRC icon
159
Ameresco
AMRC
$1.04B
$21.1M 0.15%
466,111
+192,195
+70% +$10.2M
XYL icon
160
Xylem
XYL
$29.7B
$21M 0.15%
217,433
-27,975
-11% -$2.92M
HUM icon
161
Humana
HUM
$46.7B
$20.9M 0.14%
46,662
-9,093
-16% -$4.49M
ISEE
162
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$20.8M 0.14%
930,930
-204,902
-18% -$4.49M
ZBRA icon
163
Zebra Technologies
ZBRA
$13.5B
$20.6M 0.14%
70,433
+1,602
+2% +$484K
BMO icon
164
Bank of Montreal
BMO
$127B
$20.3M 0.14%
247,787
+155,075
+167% +$14.7M
BRKR icon
165
Bruker
BRKR
$9.58B
$20.2M 0.14%
278,186
-110,000
-28% -$7.94M
MDB icon
166
MongoDB
MDB
$25B
$20.2M 0.14%
94,037
+255
+0.3% +$53.5K
EW icon
167
Edwards Lifesciences
EW
$48.2B
$20.1M 0.14%
263,794
-6,281
-2% -$494K
TRI icon
168
Thomson Reuters
TRI
$45.1B
$19.8M 0.14%
156,910
-44,731
-22% -$5.7M
KDNY
169
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$19.7M 0.14%
926,155
CLDX icon
170
Celldex Therapeutics
CLDX
$2.79B
$19.7M 0.14%
595,509
+107,000
+22% +$4.62M
BSX icon
171
Boston Scientific
BSX
$68.5B
$19M 0.13%
412,725
+16,847
+4% +$794K
BPMC
172
DELISTED
Blueprint Medicines
BPMC
$18.8M 0.13%
454,012
+195,701
+76% +$8.82M
RLAY icon
173
Relay Therapeutics
RLAY
$3.99B
$18.8M 0.13%
1,238,872
VRNS icon
174
Varonis Systems
VRNS
$5.13B
$18.7M 0.13%
779,793
MORF
175
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$18.5M 0.13%
289,933
-55,000
-16% -$2.03M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.